Pulmonary transit time of cardiovascular magnetic resonance perfusion scans for quantification of cardiopulmonary haemodynamics
暂无分享,去创建一个
A. Sauter | J. Bremerich | Joshy Cyriac | P. Haaf | M. Zellweger | F. Caobelli | I. Strebel | P. Badertscher | C. Mueller | D. Winkel | P. Lopez‐Ayala | Shan Yang | Martin Segeroth | Antonio Madaffari | Jan Gerrit van der Stouwe | J. Wasserthal | Jude Formambuh | J. G. van der Stouwe | Jakob Wasserthal
[1] A. Barkat,et al. Machine learning guided postnatal gestational age assessment using new-born screening metabolomic data in South Asia and sub-Saharan Africa , 2021, BMC Pregnancy and Childbirth.
[2] J. McMurray,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.
[3] A. Hughes,et al. Prognostic Value of Pulmonary Transit Time and Pulmonary Blood Volume Estimation Using Myocardial Perfusion CMR , 2021, JACC. Cardiovascular imaging.
[4] B. Stieltjes,et al. Automated Detection of Pancreatic Cystic Lesions on CT Using Deep Learning , 2021, Diagnostics.
[5] B. Gerber,et al. Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction. , 2021, Circulation. Cardiovascular imaging.
[6] Jens Petersen,et al. nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation , 2020, Nature Methods.
[7] D. Bluemke,et al. Reference ranges (“normal values”) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update , 2020, Journal of Cardiovascular Magnetic Resonance.
[8] R. Wachter,et al. Exercise-Stress Real-time Cardiac Magnetic Resonance Imaging for Non-Invasive Characterisation of Heart Failure with Preserved Ejection Fraction: The HFpEF Stress Trial. , 2020, Circulation.
[9] Niansheng Tang,et al. Confidence intervals of the difference between areas under two ROC curves in matched‐pair experiments , 2020, Statistics in medicine.
[10] B. Gerber,et al. Pulmonary hypertension detection by computed tomography pulmonary transit time in heart failure with reduced ejection fraction. , 2019, European heart journal cardiovascular Imaging.
[11] G. Filippatos,et al. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations , 2019, European journal of heart failure.
[12] Y. Pinto,et al. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction , 2019, Heart.
[13] Klaus H. Maier-Hein,et al. nnU-Net: Self-adapting Framework for U-Net-Based Medical Image Segmentation , 2018, Bildverarbeitung für die Medizin.
[14] R. de Caterina,et al. Prognostic value of pulmonary blood volume by first-pass contrast-enhanced CMR in heart failure outpatients: the PROVE-HF study , 2018, European heart journal cardiovascular Imaging.
[15] Meilan K. Han,et al. NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort. , 2018, Respiratory medicine.
[16] Nicola Orsini,et al. Utilizing NT-proBNP for Eligibility and Enrichment in Trials in HFpEF, HFmrEF, and HFrEF. , 2018, JACC. Heart failure.
[17] Michael Passick,et al. Prolonged central circulation transit time in patients with HFpEF and HFrEF by magnetic resonance imaging , 2018, European heart journal cardiovascular Imaging.
[18] Ingeborg H. F. Herold,et al. Noninvasive pulmonary transit time: A new parameter for general cardiac performance , 2017, Echocardiography.
[19] J. Cleland,et al. What can we learn from SOCRATES: more questions than answers? , 2017, European heart journal.
[20] M. Reisert,et al. “Nora Imaging”: A Web-Based Platform for Medical Imaging , 2017, Neuropediatrics.
[21] M. Mischi,et al. Pulmonary transit time measurement by contrast-enhanced ultrasound in left ventricular dyssynchrony , 2016, Echo research and practice.
[22] G. Filippatos,et al. Acute heart failure: Epidemiology, risk factors, and prevention. , 2015, Revista espanola de cardiologia.
[23] H. Marshall,et al. Dynamic Contrast–Enhanced Magnetic Resonance Imaging in Patients with Pulmonary Arterial Hypertension , 2014, Pulmonary circulation.
[24] M. Ugander,et al. Pulmonary blood volume indexed to lung volume is reduced in newly diagnosed systemic sclerosis compared to normals – a prospective clinical cardiovascular magnetic resonance study addressing pulmonary vascular changes , 2013, Journal of Cardiovascular Magnetic Resonance.
[25] R. Rose,et al. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors. , 2012, Journal of molecular and cellular cardiology.
[26] M. Ugander,et al. Pulmonary blood volume variation decreases after myocardial infarction in pigs: a quantitative and noninvasive MR imaging measure of heart failure. , 2010, Radiology.
[27] K. Murase,et al. Dynamic perfusion MRI: Capability for evaluation of disease severity and progression of pulmonary arterial hypertension in patients with connective tissue disease , 2008, Journal of magnetic resonance imaging : JMRI.
[28] J. Finn,et al. Heart failure: evaluation of cardiopulmonary transit times with time-resolved MR angiography. , 2003, Radiology.
[29] J. Finn,et al. Analysis of cardiopulmonary transit times at contrast material-enhanced MR imaging in patients with heart disease. , 2003, Radiology.
[30] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[31] S. Roy,et al. Pulmonary blood volume in mitral stenosis. , 1965, British medical journal.
[32] E. Faraco,et al. Determination of Pulmonary Blood Volume by Single Intravenous Injection of One Indicator in Patients with Normal and High Pulmonary Vascular Pressures , 1964, Circulation.
[33] L. Dexter,et al. The pulmonary blood volume in man. , 1961, The Journal of clinical investigation.
[34] W. Milnor,et al. Pulmonary Vascular Volume, Resistance, and Compliance in Man , 1960, Circulation.
[35] Salim Yusuf,et al. Predictors of mortality and morbidity in patients with chronic heart failure. , 2006, European heart journal.
[36] J. Karl,et al. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. , 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.